BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269
10 results:

  • 1. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
    Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
    Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive Landscape of HOXA2, hoxa9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in prostate cancer.
    Song YP; Xian P; Luo H; Dai JY; Bai Y; Li Y; Tang XL
    J Immunol Res; 2022; 2022():5740971. PubMed ID: 35372588
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment.
    Sarno F; Nebbioso A; Altucci L
    Epigenetics; 2020 May; 15(5):439-453. PubMed ID: 31790636
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TWIST1-WDR5-
    Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
    Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
    Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA
    Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder cancer.
    Xylinas E; Hassler MR; Zhuang D; Krzywinski M; Erdem Z; Robinson BD; Elemento O; Clozel T; Shariat SF
    Biomolecules; 2016 Sep; 6(3):. PubMed ID: 27598218
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HOX genes and their role in the development of human cancers.
    Bhatlekar S; Fields JZ; Boman BM
    J Mol Med (Berl); 2014 Aug; 92(8):811-23. PubMed ID: 24996520
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.
    Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ
    Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation and management of men whose radical prostatectomies failed: results of an international survey.
    Ornstein DK; Colberg JW; Virgo KS; Chan D; Johnson ET; Oh J; Johnson FE
    Urology; 1998 Dec; 52(6):1047-54. PubMed ID: 9836553
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.